Riskpilot← Back to searchSign inGet full accessPostfestum AB
ABActiveOrg 5569122251Nyängsvägen 90Medical specialists activities · NACE 8622Est. 20120 employees
Revenue 2025
SEK 1,1M
+420% vs 2024
EBITDA margin
39.1%
+334% vs 2024
Equity ratio
86.0%
Financial strength
Net profit 2025
SEK -44K
+32% vs 2024
| Revenue | SEK 1,1M | +420% |
| EBITDA | SEK 442K | +334% |
| Net profit | SEK -44K | +32% |
| Total assets | SEK 9,2M | -9% |
| Equity | SEK 7,9M | -5% |
| Employees | 0 | — |
Legal name
Postfestum AB
Org number
5569122251
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
29 november 2012
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva sjukvårdsverksamhet samt därmed förenlig verksamhet.
Address
Nyängsvägen 90
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 605 | 521 | 380 | 217 | 1 130 |
| Staff expenses | — | — | −89 | −35 | −101 |
| EBITDA | −225 | −276 | −463 | −189 | 442 |
| Depreciation & amort. | −0 | −0 | — | −9 | −17 |
| EBIT | −225 | −276 | −463 | −198 | 424 |
| Net financials | 1 198 | 1 498 | 580 | −0 | −369 |
| Profit before tax | 1 231 | 1 481 | 3 975 | −64 | 56 |
| Tax | −11 | −0 | −702 | — | −99 |
| Net profit | 1 220 | 1 481 | 3 273 | −64 | −44 |
| Item | 2022 | 2023 | 2024 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 6 088 | 8 983 | 10 496 | 10 175 | 9 211 |
| Equity | 3 681 | 5 162 | 8 435 | 8 371 | 7 918 |
| Long-term debt | 2 000 | 3 650 | — | — | — |
| Short-term debt | 14 | 37 | 797 | 674 | 163 |
| Total debt | 2 014 | 3 687 | 797 | 674 | 163 |
EBITDA margin
39.1%
This company
15.8%
Market median
+147% vs market
20222025
Equity ratio
86.0%
This company
38.2%
Market median
+125% vs market
20222025
Return on equity
-0.5%
This company
18.4%
Market median
-103% vs market
20222025
Net profit margin
-3.9%
This company
8.1%
Market median
-148% vs market
20222025
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
20222025
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-11-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-05-01 – 2024-10-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Postfestum AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ebba Christina Blomqvist | Deputy Board Member | 0 companies |
| Karl Lennart Blomqvist | Board of Directors | 0 companies |